Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
March 1, 1989
Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent
S K Puri, R S Hsu, I Ho, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1992
Lack of interaction between cefpirome and alcohol
H B Lassman, J W Hubbard, B L Chen, et al.
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1970
On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors
C M Ambrus, J L Ambrus, H B Lassman, et al.
The Journal of Clinical Psychiatry
|
April 1, 1984
The pharmacokinetics and bioavailability of nomifensine maleate in healthy men
H B Lassman, S K Puri, I Ho, et al.
Drugs
|
January 1, 1988
The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men
H B Lassman, I Ho, S K Puri, et al.
Journal of Clinical Pharmacology
|
February 1, 1988
Pharmacokinetics of roxithromycin (RU 965)
H B Lassman, S K Puri, I Ho, et al.
Pediatric Research
|
January 1, 1970
Changes in fibrin-stabilizing factor levels in relation to maternal hemorrhage and neonatal disease
C M Ambrus, J L Ambrus, K R Niswander, et al.
Agents and Actions
|
April 1, 1978
Fendosal (HP 129): a potent anti-inflammatory and analgesic compound
H B Lassman, J C Wilker, V B Anderson, et al.
The Annals of Pharmacotherapy
|
July 1, 1996
Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency
C M Paap, K S Simpson, M W Horton, et al.
Journal of Medicinal Chemistry
|
February 11, 1976
Carboxyarylindoles as nonsteroidal antiinflammatory agents
V B Anderson, M N Agnew, R C Allen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
March 1, 1989
Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent
S K Puri, R S Hsu, I Ho, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1992
Lack of interaction between cefpirome and alcohol
H B Lassman, J W Hubbard, B L Chen, et al.
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1970
On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors
C M Ambrus, J L Ambrus, H B Lassman, et al.
The Journal of Clinical Psychiatry
|
April 1, 1984
The pharmacokinetics and bioavailability of nomifensine maleate in healthy men
H B Lassman, S K Puri, I Ho, et al.
Drugs
|
January 1, 1988
The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men
H B Lassman, I Ho, S K Puri, et al.
Journal of Clinical Pharmacology
|
February 1, 1988
Pharmacokinetics of roxithromycin (RU 965)
H B Lassman, S K Puri, I Ho, et al.
Pediatric Research
|
January 1, 1970
Changes in fibrin-stabilizing factor levels in relation to maternal hemorrhage and neonatal disease
C M Ambrus, J L Ambrus, K R Niswander, et al.
Agents and Actions
|
April 1, 1978
Fendosal (HP 129): a potent anti-inflammatory and analgesic compound
H B Lassman, J C Wilker, V B Anderson, et al.
The Annals of Pharmacotherapy
|
July 1, 1996
Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency
C M Paap, K S Simpson, M W Horton, et al.
Journal of Medicinal Chemistry
|
February 11, 1976
Carboxyarylindoles as nonsteroidal antiinflammatory agents
V B Anderson, M N Agnew, R C Allen, et al.
Page
of 3